UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely DBV Technologies is implementing good security practices.
DBV Technologies SA is a publicly owned, French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood.
This report shows a preliminary security rating for DBV Technologies. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
The average cost of a data breach is now nearly $4 million and the unfortunate truth is ...
The NIST Cybersecurity Framework provides a framework, based on existing standards, guidelines and ...
Compare DBV Technologies's security performance with other companies